LifeTech Scientific Corporation 1302
HKEX · Çin Hong Kong ÖİB · Sağlık Teknolojisi
HKD 1,30-0,09 (-%6,81)
Piyasa açık· · HKD · Veriler gecikmeli olabilir
Fiyatlar gecikmeli olabilir ve yalnızca bilgilendirme amaçlıdır - yatırım tavsiyesi değildir.
Piyasa açık· · HKD · Veriler gecikmeli olabilir
Fiyatlar gecikmeli olabilir ve yalnızca bilgilendirme amaçlıdır - yatırım tavsiyesi değildir.
LifeTech Scientific Corporation ("LifeTech" or the "Company", together with its subsidiaries, the "Group", stock code: 1302.HK), a medical device company specializing in minimally invasive interventional solutions for cardio-cerebrovascular and peripheral vascular diseases, today announced its unaudited consolidated results for the six months ended 30 June 2026 (the "Reporting Period").
As the Asian markets navigate a complex landscape marked by central banks holding rates steady amid geopolitical uncertainties, investors are keenly observing the opportunities that arise from these conditions. Penny stocks, often representing smaller or newer companies, continue to capture attention for their potential to offer growth at accessible price points. Despite being a somewhat outdated term, penny stocks remain relevant as they can provide significant upside when backed by strong...
As global markets navigate the complexities of Middle East tensions and energy market volatility, investors are closely monitoring shifts in financial landscapes. Amid these conditions, penny stocks—though an outdated term—remain a focal point for those interested in smaller or newer companies with potential value. By examining stocks with solid financial foundations, investors can uncover opportunities that may offer both stability and growth potential within the Asian market.
Üçüncü taraf yayıncıların bu şirket hakkındaki son başlıkları; Makkler'in kendi editoryal içeriğinden ayrı tutulur ve dış kaynağa yönlendirir. Başlıkların doğruluğu ilgili yayıncının sorumluluğundadır.